GHALIA AL AZMEH
Allopathic & Osteopathic Physicians|Internal Medicine GAINESVILLE, GA NPI 1386148583
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine GA Medtronic, Inc. All categories
General Payments — all program years on this page
$591.05
- Category: General Payments
- Program years: PY2022–2024
- Record count: 27
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $180.53 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $180.53 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $38.80 | 1 |
| DEXCOM, INC. | $33.21 | 2 |
| SANOFI-AVENTIS U.S. LLC | $21.38 | 1 |
| GlaxoSmithKline, LLC. | $19.73 | 1 |
| Lilly USA, LLC | $19.37 | 1 |
| Acerta Pharma LLC | $18.49 | 1 |
| Novo Nordisk AS | $15.81 | 1 |
| PFIZER INC. | $13.74 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096602317 | Novo Nordisk Inc | $15.81 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104336836 | AstraZeneca Pharmaceuticals LP | $18.49 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116347862 | GlaxoSmithKline, LLC. | $19.73 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119294181 | Medtronic, Inc. | $38.80 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132033923 | PFIZER INC. | $13.74 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1134988050 | Lilly USA, LLC | $19.37 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139953460 | SANOFI-AVENTIS U.S. LLC | $21.38 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153301683 | Dexcom, Inc. | $14.25 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153301685 | Dexcom, Inc. | $18.96 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.